Citius Oncology, Inc.
Citius Oncology, Inc. (CTOR) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
CTOR · net income · updated Jun 9, 2026
Core profitability metrics
CTOR · net income · margin · TTM · CAGRNet income was −$24.8M for FY2025 (fiscal year ending 2025-09-30), down 17.1% year-over-year. Net profit margin was —.
Annual net income history
▸ FMP /income-statement · Annual · CTOR net income history · CTOR profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Citius Oncology, Inc. (CTOR) reported net income of −$24.8M for FY2025 (fiscal year ending 2025-09-30), down 17.1% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.
Citius Oncology, Inc. has not yet achieved annual profitability based on available data (4 fiscal years). The company has reported net losses across all available periods.
Citius Oncology, Inc.'s net profit margin was — for FY2025, based on the latest annual results.
Investors sometimes search for "Citius Oncology, Inc. net worth" — the company's market capitalization is a separate figure from CTOR net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
CTOR net income · 4 questionsCitius Oncology, Inc. is not currently profitable on an annual basis. The company reported a net loss of $24.8M for FY2025.
▸ Source: FMP /income-statement · GAAP · Citius Oncology, Inc. · Citius Oncology, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026